Company · mentioned 27 times
AI drug discovery company based in London, spun out of Google DeepMind and backed by Alphabet, focused on designing new medicines using artificial intelligence.
My First Million· 9 Nov
Shaan Puri says Google owns a company called Isomorphic, where Demis Hassabis, the founder of DeepMind who was running AI, is now focused on curing cancer.Invest Like the Best with Patrick O'Shaughnessy· 6 Nov
Ramtin Naimi says New Limit, Chai Discovery and Isomorphic are among the next generation of companies he expects to look at five years from now.Masters of Scale· 5 Nov
Demis Hassabis's personal projects include AlphaFold and the drug discovery spin-out company Isomorphic Labs.The Twenty Minute VC (20VC): Venture Capital | Startup Funding | The Pitch· 15 Oct
Rory O'Driscoll argues Isomorphic captures value by making discoveries, with a 10% royalty on a $200 billion drug.Minus One· 24 Sept
Helmy Eltoukhy declines to speak for Isomorphic Labs but says existing biological data are not good and the field is undersampling by as much as 1,000x.